Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2008
03/05/2008CN101137380A Quinazolinone t-type calcium channel antagonists
03/05/2008CN101137377A Tetracyclic amino and carboxamido compounds and methods of use thereof
03/05/2008CN101137372A Mitotic kinesin inhibitors
03/05/2008CN101137371A Process for preparing lansoprazole
03/05/2008CN101134755A Quinazoline(di) ones for invertebrate pest control
03/05/2008CN100372838C Piperidine-benzenesulfonamide derivatives
03/05/2008CN100372836C Immunotherapeutic imides/amides
03/05/2008CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists.
03/04/2008US7339064 Benzimidazole compound crystal
03/04/2008US7339057 Reacting methanesulfonyl chloride with 3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid, reacting with 2-amino-3-methyl-5-chlorobenzoic acid to produce -[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-6-chloro-8-methyl-4H-3,1-benzoxazin-4-one
03/04/2008US7338978 Insecticidal anthranilamides
03/04/2008US7338976 Administering heterocyclic esters and amides: 3-phenyl-1-propyl(2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-(4-thiazolidine)carboxylate; 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; immunosuppressants; affinity for an FK binding protein-type immunophilin
03/04/2008US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors
03/04/2008US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease
03/04/2008US7338963 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 3-(4-methoxy-phenyl)-5-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-3,5,6,7-tetrahydro-[1,2,3]triazolo4,5-c]pyridin-4-one; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis
03/04/2008US7338962 Spirocyclic heterocyclic derivatives and methods of their use
03/04/2008US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent
03/04/2008US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
03/04/2008US7338951 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis
03/04/2008US7338950 Amide compounds as ion channel ligands and uses thereof
03/04/2008US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis
03/04/2008US7338721 Condensed polycyclic compound and organic light-emitting device using the same
02/2008
02/28/2008WO2008024974A1 Pyrimidine and pyrazine derivatives
02/28/2008WO2008024784A1 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors
02/28/2008WO2008023720A1 Urea compound or salt thereof
02/28/2008WO2008023698A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
02/28/2008WO2008023628A1 Compound having triazine ring structure substituted with pyridyl group and organic electroluminescent device
02/28/2008WO2008023336A2 Matrix metalloproteinase inhibitors
02/28/2008WO2008023258A1 Piperidine derivatives
02/28/2008WO2008023239A1 Pyrimidone compounds as gsk-3 inhibitors
02/28/2008WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents
02/28/2008WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/28/2008WO2008023066A1 Imidazole compounds having an antiinflammatory effect
02/28/2008WO2008022979A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds
02/28/2008WO2008022962A2 Method for producing n-piperidinyl-benzodiazepines having cgrp-antagonistic properties
02/28/2008WO2008022945A1 Aryl sulfonamides with an analgesic action
02/28/2008WO2008007123A3 Pharmaceutical compounds
02/28/2008WO2008002868A3 Pyridinium salts for polymer composites and methods for their preparation
02/28/2008WO2008000692A3 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity
02/28/2008WO2007139967A3 Triazole compounds that modulate hsp90 activity
02/28/2008WO2007104034A3 Glucokinase activators
02/28/2008WO2007033366A8 Biphenyl-pyrazolecarboxamide compounds
02/28/2008US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer
02/28/2008US20080051433 Pyrrole-3-Carboxamide Derivatives for the Treatment of Obesity
02/28/2008US20080051430 Dietetics; antidiabetic agents; sexual disorders
02/28/2008US20080051418 Arylalkanoic Acid Derivative
02/28/2008US20080051415 Novel piperazines, pharmaceutical compositions and methods of use thereof
02/28/2008US20080051414 Protein Kinase Inhibitors
02/28/2008US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer
02/28/2008US20080051396 Costunolide derivatives
02/28/2008US20080051387 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
02/28/2008US20080051384 Antiviral agents
02/28/2008US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use
02/28/2008US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
02/28/2008US20080050336 Hepatitis C Virus Inhibitors
02/28/2008CA2665804A1 Urea compound or salt thereof
02/28/2008CA2663598A1 New compounds
02/28/2008CA2661778A1 New production method
02/28/2008CA2661503A1 Inhibitors of 11.beta. -hydroxysteroid dehydrogenase type 1
02/28/2008CA2661436A1 Isoquinoline, quinazoline and phthalazine derivatives
02/28/2008CA2661333A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
02/28/2008CA2661299A1 Matrix metalloproteinase inhibitors
02/28/2008CA2661187A1 Piperidine derivatives
02/28/2008CA2657183A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds
02/27/2008EP1892239A1 Inhibitors of cytosolic phospholipase A2
02/27/2008EP1891954A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
02/27/2008EP1891951A1 Viral polymerase inhibitors
02/27/2008EP1891950A1 Viral polymerase inhibitors
02/27/2008EP1891076A1 Substituted tetrahydroquinolines
02/27/2008EP1891063A2 Bicyclic derivatives as modulators of ion channels
02/27/2008EP1891057A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators
02/27/2008EP1891048A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
02/27/2008EP1891047A2 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
02/27/2008EP1891046A1 Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
02/27/2008EP1891045A2 Pyridine compounds for combating arthropod pests and nematodes
02/27/2008EP1891044A1 Crystalline forms of a known pyrrolidine factor xa inhibitor
02/27/2008EP1891043A1 Amorphous esomeprazole hydrate
02/27/2008EP1891042A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their therapeutic use on the central nervous system
02/27/2008EP1891041A1 METABOLITES OF 1- [-6- (1-ETHYL-l-HYDROXY-PROPYL) -PYRIDIN-3-YL]-3- [2- (4-METHYL-PIPERAZIN-I-YL) -BENZYL]-PYRR0LIDIN-2-0NE AS SERATONIN RECEPTOR ANTAGONISTS
02/27/2008EP1891040A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis
02/27/2008EP1891039A1 Quinoline derivatives useful as modulators of ion channels
02/27/2008EP1891038A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
02/27/2008EP1891037A1 Gemifloxacin process and polymorphs
02/27/2008EP1891036A1 Alpha 7 nicotinic receptor selective ligands
02/27/2008EP1891017A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases
02/27/2008EP1891013A1 Tetrahydroquinoline derivatives
02/27/2008EP1890703A2 Pyrimidine compounds
02/27/2008EP1802307B1 Pyrrolidine derivatives as histamine receptors ligands
02/27/2008EP1773810B1 New 4-benzylidene-piperidin derivatives
02/27/2008EP1610786B9 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's
02/27/2008EP1471065B1 Novel 1,2,4-triazole compound
02/27/2008EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
02/27/2008EP1395564B1 Quinoline derivatives as ligands for the neuropeptide y receptor
02/27/2008EP1318994B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
02/27/2008EP1248612B1 Novel compounds and compositions as protease inhibitors
02/27/2008EP1246806B1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
02/27/2008EP0896578B1 NOVEL IMIDAZO[1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS
02/27/2008CN101133050A Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
02/27/2008CN101133049A Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
02/27/2008CN101133048A Preparation of pharmaceutical salts of piperazine compounds